Seeking Alpha

Shares of drug maker Shire (SHPGY, SHPGF.PK) -13% in London trading on news the FDA approved a...

Shares of drug maker Shire (SHPGY, SHPGF.PK) -13% in London trading on news the FDA approved a generic version of its attention-deficit and hyperactivity drug Adderall XR. Watson Pharma's (WPI) newly acquired Actavis division obtained an abbreviated new-drug application for the generic. SHPGY -12.2%, WPU +1.9% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)